New treatment option for Pelvic Bone Injury
Official title Impact of a Clinical Pathway for Pelvic Fragility Fractures
ClinicalTrials.gov ID: NCT06054165
What this study is testing
- What it's testing
- Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Pelvic fragility fracture caused by low energetic trauma
- Patients presented at the emergency room or out-patient clinic of a participating hospital
You likely can't join if
- Patients with high suspicion of a pelvic fracture due to a malignant tumor
- Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)
- Patients who pre-trauma received palliative or terminal care
- Patients who pre-trauma were wheelchair bound or bedridden
- Patients who suffer from complications from previous pelvic ring fixation
- Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
The study team makes the final eligibility decision.
Where it's taking place
- Almere Stad, Flevoland, Netherlands
- Alkmaar, North Holland, Netherlands
- Amsterdam, North Holland, Netherlands
- Haarlem, North Holland, Netherlands
- Hoorn, North Holland, Netherlands
- Zaandam, North Holland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Almere Stad, Flevoland, Netherlands; Alkmaar, North Holland, Netherlands; Amsterdam, North Holland, Netherlands; Haarlem, North Holland, Netherlands; Hoorn, North Holland, Netherlands; Zaandam, North Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.